Cette page est disponible uniquement en anglais

Go-to full-service advisor in the Benelux life sciences and healthcare industry

NautaDutilh provides truly integrated services to clients in the life sciences & healthcare sector. Our dedication to and focus on the pharma, biotech, medtech and healthcare industries has resulted in a broad recognition as go-to full-service advisor in the Benelux life sciences and healthcare industry; from top notch regulatory advice, to advising on the most complex Corporate M&A deals, financings and representing clients in high end IP and product liability litigation. Other services include advice on sector specific competition law issues, advertising regulations, data protection and government affairs, as well as other relevant areas of expertise (including employment, tax, real estate etc.).

We advise national and international clients in the healthcare, pharmaceutical, biotechnology and medical devices sectors, from start-ups to market leaders.

Thanks to our extensive experience and active participation in many large professional organisations (for example, HollandBio and flanders.bio) we have built a powerful network and have comprehensive knowledge of the sector. Our lawyers publish and speak regularly on subjects such as competition, intellectual property, and financing in the pharmaceutical, biotech and medical devices sectors.

  • Full service approach

    NautaDutilh's Healthcare & Life Sciences team takes a holistic approach and is composed of lawyers from various practice groups (including regulatory, IP, public procurement, privacy, competition, M&A and finance specialists). This enables us to provide the full range of advisory, litigation and transactional services, tailored to meet our clients' needs at all stages of their product and business cycles: from a company’s incorporation, financing rounds and investment arrangements to acquisition by listed companies or another form of exit such as an IPO. For business operations we assist with contracting (including licensing), intellectual property related issues, risk management and compliance. As a result of our dedication and attention to the life sciences sector, we are now widely recognised among industry players as one of the go-to full-service advisers in the Benelux.

    Our Healthcare &Life Sciences team advises both domestic and international clients – ranging from start-ups to industry leaders and academic research centers – in the pharmaceutical, biotechnology and medical devices fields, in transactional matters and dealings with the regulators and, if necessary, before the courts.

  • Highlighted work

    The Healthcare & Life Sciences team boasts the largest Dutch pharma deal (in size) ever: AstraZeneca's up to USD 7 billion acquisition of Acerta Pharma. They advised Batavia Biosciences on is auction sale to CJ, Onward Medical on is Euronext IPO, Cerba Healthcare on its acquisition of Viroclinics, NewAmsterdam Pharma on its de-SPAC transaction with Frazier Healthcare and Gingko Bioworks on its acquisition of Dutch DNA.

    They have also performed ongoing venture capital work concerning various successful biotech, pharma, agrotech and medical devices companies. At the same time, it provides high-end regulatory and litigation services with regard to product launches and distribution, advertising, clinical trials, generic entry, patent litigation and product liability issues, to name a few.

    We work for a number of reputable life sciences companies and investors such as Abacus Medicine, Allergan, AstraZeneca, Azalea Vision, Bausch Health companies Inc., Eagle Pharmaceuticals, EQT Life Sciences, Gadeta, Gilead, Forbion Growth GlaxoSmithKline, Illumina, Imcyse, Incyte, InflaRx, Mediq, Merus, Morrow, Nyxoah, Onward Medical, Pfizer, Pharming, Sanofi, and Vico Therapeutics International.

    Our client portfolio also includes various investment banks involved in IPOs and capital market transactions, such as Cowen and Company, Kempen & Co, Jefferies LLC, SVB Leerink, Piper Jaffray & Co, UBC and Wedbush Securities.

    Our Track records

    Life Sciences track record Corporate

    Life Sciences track record Capital Markets

    Life Sciences track record IP and Regulatory Law

    Life Sciences track record Litigation

  • What others say
    • ‘The NautaDutilh team provides a wonderful service to clients.’
      The Legal 500 2023
    • ‘The approach taken by the NautaDutilh team is very creative, but at the same time based on a thorough search about the laws, precedents and recent tendency of the relevant courts.’
      The Legal 500 2023
    • ‘What is unique for the team is that, although Ms. Verhoestraete and Mr. de Haan are both experienced, top-class IP litigators, they form a team and collaborate as equal partners rather than senior-junior attorneys. They complement each other in formulating strategies, arguments or recommendations in a variety of difficult aspects of litigations. Also, their view is based on vast and deep experience in IP litigations and they can bridge legal analysis and commercial interests for clients in a creative manner.’
      The Legal 500 2023
    • ‘High level of responsiveness and good understanding of the dynamics, in particular in an M&A context.
      The Legal 500 2023
    • ‘Reliability and friendliness in the collaboration.’
      The Legal 500 2023
    • ‘Most experienced team in Benelux – pragmatic to work with and focused on optimizing the best commercial deal.’
      The Legal 500 2023
    • ‘Nauta-Dutilh is a great practice with a great supportive team for companies with a Dutch presence. They are a rare group that actually tries to understand what is needed and what is asked and to do it in the best, simplest way possible. They provide good, realistic and pragmatic legal advice.’
      The Legal 500 2023
    • ‘Ruud Smits is an amazing legal advisor. He is the most pragmatic lawyer I have had a chance to work with. A true legal partner. The rest of the team is also very reliable, responsive and helpful.’
      The Legal 500 2023
    • ‘The team at NautaDutilh is very well-versed and capable in complex cross-border transactions in the Life Sciences field. From our perspective, they are a leading firm in Belgium in this field and have an experienced team, comprised of professionals with different specialisations.’
      The Legal 500 2022
    • ‘Philippe Remels is very experienced with transactional matters and an excellent partner to work with on cross-border mandates. I greatly appreciate his friendly and collaborative approach.’
      The Legal 500 2023

Notification de cookies

Cette fonctionnalité utilise des cookies tiers. Modifiez votre cookie préférences pour visualiser ce contenu ou afficher plus d'informations.
Ces cookies assurent le bon fonctionnement du site. Ces cookies ne peuvent pas être désactivés.
Ces cookies peuvent être placés par des tiers, tels que YouTube ou Vimeo.
En désactivant certaines catégories, les fonctionnalités associées au sein du site risquent de ne plus fonctionner correctement. Vous pouvez modifier vos préférences ultérieurement. Voir plus d'informations.